16.30
price down icon2.05%   -0.275
 
loading

Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten

pulisher
09:00 AM

Bausch + Lomb Corporation Investigated by the Portnoy Law Firm - GlobeNewswire Inc.

09:00 AM
pulisher
Mar 12, 2026

Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position - AOL.com

Mar 12, 2026
pulisher
Mar 11, 2026

Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Mar 11, 2026
pulisher
Mar 10, 2026

Bausch And Lomb (NYSE:BLCO) Glaucoma Moves Catch Market Eyes Nyse Composite Today - Kalkine Media

Mar 10, 2026
pulisher
Mar 10, 2026

Bausch & Lomb (NYSE: BLCO) CFO buys 4,000 shares, gets 4,000 RSUs - Stock Titan

Mar 10, 2026
pulisher
Mar 09, 2026

Bausch + Lomb Corporation - Baystreet.ca

Mar 09, 2026
pulisher
Mar 09, 2026

Inside Bausch + Lomb’s glaucoma webinar on new treatments - Stock Titan

Mar 09, 2026
pulisher
Mar 08, 2026

Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Latest Revenue And Net Loss Update - Yahoo Finance

Mar 08, 2026
pulisher
Mar 06, 2026

Short Covering: Will Bausch Lomb Corporation outperform its industry peersJuly 2025 Levels & Fast Moving Market Watchlists - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - Finviz

Mar 06, 2026
pulisher
Mar 04, 2026

Insider Buying: Ross Thomas W. Sr. Acquires Shares in Bausch & L - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Director adds BLCO stake with 4,500-share buy and 4,500 RSUs grant - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Potential Bausch + Lomb Separation Reframes Bausch Health - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

Insider Buying: Eduardo Alfonso Acquires Shares of Bausch & Lomb Corp (BLCO) - GuruFocus

Mar 04, 2026
pulisher
Mar 03, 2026

[Form 4] Bausch & Lomb Corp Insider Trading Activity - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Bausch & Lomb (NYSE: BLCO) director buys shares, gets RSUs - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

BLCO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Bausch & Lomb (NYSE: BLCO) SVP disposes shares for taxes - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch & Lomb (BLCO) officer has shares withheld for RSU tax - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Tax-withholding share moves by Bausch & Lomb (NYSE: BLCO) executive - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch & Lomb (BLCO) EVP uses share withholding to cover tax on RSU vesting - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch & Lomb (BLCO) EVP uses shares for tax withholding on RSU vesting - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

CFO tax share withholding at Bausch & Lomb (BLCO) after RSU vesting - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch & Lomb (BLCO) CEO uses common shares to cover RSU tax - Stock Titan

Mar 02, 2026
pulisher
Feb 27, 2026

Bausch & Lomb (BLCO) SVP awarded 18,253 restricted share units in Form 4 - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Executive at Bausch & Lomb (NYSE: BLCO) granted 32,710 restricted share units - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Bausch & Lomb (NYSE: BLCO) EVP awarded 35,046 restricted share units - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

327,102-share RSU award to Bausch & Lomb (BLCO) CEO Brent Saunders - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Bausch + Lomb Corp. Hits New 52-Week High at $18.91 - Markets Mojo

Feb 27, 2026
pulisher
Feb 27, 2026

Bausch + Lomb Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Feb 27, 2026
pulisher
Feb 27, 2026

Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth - Insider Monkey

Feb 27, 2026
pulisher
Feb 26, 2026

Bausch + Lomb stock hits 52-week high at $18.86 - Investing.com Australia

Feb 26, 2026
pulisher
Feb 25, 2026

Bausch + Lomb stock hits 52-week high at $18.86 By Investing.com - Investing.com Canada

Feb 25, 2026
pulisher
Feb 25, 2026

Bausch & Lomb (BLCO) CEO uses 65,444 shares to cover tax withholding - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Is Expert Backing Of LUMIFY’s Safety Profile Quietly Shaping Bausch + Lomb’s Consumer Strategy (BLCO)? - simplywall.st

Feb 25, 2026
pulisher
Feb 25, 2026

5 Revealing Analyst Questions From Bausch + Lomb's Q4 Earnings Call - Finviz

Feb 25, 2026
pulisher
Feb 24, 2026

Director Steven Collis adds BLCO stake with 15,000-share buy and RSU grant - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

Director boosts Bausch & Lomb (BLCO) stake with share buy and matching RSUs - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

Is It Time To Reassess Bausch + Lomb (BLCO) After Its Recent Share Price Strength? - Yahoo Finance

Feb 24, 2026
pulisher
Feb 24, 2026

H.C. Wainwright raises Bausch & Lomb stock price target to $20 - Investing.com South Africa

Feb 24, 2026
pulisher
Feb 24, 2026

H.C. Wainwright raises Bausch & Lomb stock price target to $20 By Investing.com - Investing.com Canada

Feb 24, 2026
pulisher
Feb 24, 2026

HC Wainwright Comments on Bausch + Lomb Q1 Earnings - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Digital lifestyles are turning eyes red – and one drop stands out - Stock Titan

Feb 24, 2026
pulisher
Feb 23, 2026

Adding B Vitamins To AREDS Has Bausch + Lomb Seeing Consumer Health Sales Boost Ahead - Citeline News & Insights

Feb 23, 2026
pulisher
Feb 23, 2026

Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey

Feb 23, 2026
pulisher
Feb 23, 2026

Director Karen Ling adds Bausch & Lomb (BLCO) shares and gets 4,000 RSUs - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Director receives 5,255 RSUs at Bausch & Lomb (NYSE: BLCO) - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Bausch & Lomb (BLCO) awards 5,255 RSUs to director - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Director at Bausch & Lomb (BLCO) receives 1,451 restricted share units - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Director John Paulson granted 1,239 Bausch & Lomb (BLCO) restricted share units - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $20 - 富途牛牛

Feb 23, 2026
pulisher
Feb 20, 2026

Bausch & Lomb (NYSE: BLCO) EVP earns 29,406 performance-based shares - Stock Titan

Feb 20, 2026
$66.85
price up icon 1.17%
$166.75
price down icon 0.01%
medical_instruments_supplies COO
$70.45
price down icon 1.49%
$75.27
price up icon 0.09%
medical_instruments_supplies WST
$235.32
price up icon 1.87%
$41.15
price up icon 0.44%
Kapitalisierung:     |  Volumen (24h):